B-OM should have a very nice revenue stream but it will pale compared to the other more lucrative possibilities for B. I don't mind getting a nice chunk of change now in upfront payment for OM to prevent dilution when I know the really big revenue streams for B are still under our control. We all know we still have to pay up for upcoming expenses and I feel the OM indication is a perfect one to be the sacrificial lamb to bring in the first influx of funds.
Very, very interested to see what BP gets the OM license as they may be the favored partner down the line.
(4)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links